![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1562, 2006-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Docetaxel boosts response to chemotherapy in patients with early breast cancer
Inpharma, Vol. 1, Iss. 1223, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Montero Alberto Booser Daniel Esparza-Guerra Laura Murray James Rosales Marguerite Hortobagyi Gabriel Valero Vicente
Drugs in R&D, Vol. 6, Iss. 5, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Economic evaluation of docetaxel for breast cancer
Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Docetaxel: a workhorse in breast cancer therapy
Inpharma, Vol. 1, Iss. 1273, 2001-01 ,pp. :